Mckesson (MCK) Land & Improvements (2025 - 2026)
Mckesson (MCK) reported Land & Improvements of $102.0 million for Q1 2026, down 1.92% year-over-year from $104.0 million in Q1 2025, and down 1.92% quarter-over-quarter from $104.0 million in Q1 2025.
Mckesson (MCK) Land & Improvements (2025 - 2026) Analysis & Trends
Mckesson (MCK) has 2 years of Land & Improvements data on file, last reported at $102.0 million in Q1 2026.
- Land & Improvements for Q1 2026 came in at $102.0 million, down 1.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $102.0 million (down 1.92% YoY), and the FY2026 annual result was $102.0 million, down 1.92% from the prior year.
- Land & Improvements fell to $102.0 million in Q1 2026 per MCK's latest filing, from $104.0 million in the prior quarter.
- Over five years, Land & Improvements peaked at $104.0 million in Q1 2025 and troughed at $102.0 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 102.00 Mn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | - |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | - |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | - |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | - |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | - |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | - |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 3.70 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102.00 Mn |
| Mar 31, 2025 | 104.00 Mn |